Acute heart failure: mechanisms and pre-clinical models—a scientific statement of the ESC Working Group on Myocardial Function

M Ciccarelli, IF Pires, J Bauersachs… - Cardiovascular …, 2023 - academic.oup.com
While chronic heart failure (CHF) treatment has considerably improved patient prognosis
and survival, the therapeutic management of acute heart failure (AHF) has remained virtually …

Chronic heart failure management: monitoring patients and intercepting exacerbations

G Piccirillo, F Moscucci, S Sciomer… - Reviews in …, 2023 - pmc.ncbi.nlm.nih.gov
Despite significant progress in the field of therapy and management, chronic heart failure
(CHF) still remains one of the most common causes of morbidity and mortality, especially …

Canadian Cardiovascular Society-Canadian Heart Failure Society focused clinical practice update of patients with differing heart failure phenotypes

A Ducharme, S Zieroth, V Ahooja, K Anderson… - Canadian Journal of …, 2023 - Elsevier
A number of societies produce heart failure (HF) management guidelines, comprising official
recommendations on the basis of recent research discoveries, but their applicability to …

Differences in the biomarker profile of de novo acute heart failure versus decompensation of chronic heart failure

S Nawrocka-Millward, J Biegus, M Hurkacz, M Guzik… - Biomolecules, 2021 - mdpi.com
The perception of acute heart failure (AHF) as a single entity is increasingly outdated, as
distinct patient profiles can be discerned. Key heart failure (HF) studies have previously …

Acute heart failure: Differential diagnosis and treatment

M Marini, R Manfredi, I Battistoni… - European Heart …, 2023 - academic.oup.com
Acute heart failure is a heterogeneous clinical syndrome and is the first cause of unplanned
hospitalization in people> 65 years. Patients with heart failure may have different clinical …

mortality after the first hospital admission for acute heart failure, De Novo versus acutely decompensated heart failure with reduced ejection fraction

R López-Vilella, PJ Pastor, VD Trenado… - The American Journal of …, 2023 - Elsevier
It is not clear to date whether a first admission in heart failure (HF) marks a worse evolution
in patients not previously diagnosed with HF (“de novo HF”) than those already diagnosed …

[HTML][HTML] Hemodynamic Differences between Patients Hospitalized with Acutely Decompensated Chronic Heart Failure and De Novo Heart Failure

A Galas, P Krzesiński, M Banak, G Gielerak - Journal of Clinical Medicine, 2023 - mdpi.com
Background: Heart failure (HF) is associated with high mortality, morbidity, and frequent
hospitalizations due to acute HF (AHF) and requires immediate diagnosis and individualized …

Meteorin‐like protein plasma levels are associated with worse outcomes in de novo heart failure

L Anido‐Varela, A Aragón‐Herrera… - European Journal of …, 2025 - Wiley Online Library
Abstract Background and Aims Meteorin‐like protein (Metrnl) has been recently suggested
as a new adipokine with protective cardiovascular effects. Its circulating levels in patients …

Effects of sacubitril/valsartan vs valsartan in de novo vs acute on chronic HFpEF and HFmrEF

EM Murray, D Cyr, M Fudim, JH Ward, AF Hernandez… - JACC: Advances, 2024 - jacc.org
Background Decompensated heart failure (HF) can be categorized as de novo or worsening
of chronic HF. In PARAGLIDE-HF (Prospective comparison of ARNI with ARB Given …

Sphericity index for bedside diagnosis of acute myocarditis

A AbdelMassih, S El-Saiedi, R Hendawy… - Egyptian Pediatric …, 2023 - Springer
Background Differentiating acute myocarditis (AMY) from dilated cardiomyopathy (DCM) in a
patient presenting with acute heart failure and poor systolic function is of utmost importance …